BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 16636116)

  • 1. Transient hemophagocytosis with deficient cellular cytotoxicity, monoclonal immunoglobulin M gammopathy, increased T-cell numbers, and hypomorphic NEMO mutation.
    Pachlopnik Schmid JM; Junge SA; Hossle JP; Schneider EM; Roosnek E; Seger RA; Gungor T
    Pediatrics; 2006 May; 117(5):e1049-56. PubMed ID: 16636116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nuclear factor kappaB essential modulator-deficient child with immunodeficiency yet without anhidrotic ectodermal dysplasia.
    Niehues T; Reichenbach J; Neubert J; Gudowius S; Puel A; Horneff G; Lainka E; Dirksen U; Schroten H; Döffinger R; Casanova JL; Wahn V
    J Allergy Clin Immunol; 2004 Dec; 114(6):1456-62. PubMed ID: 15577852
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human nuclear factor kappa B essential modulator mutation can result in immunodeficiency without ectodermal dysplasia.
    Orange JS; Levy O; Brodeur SR; Krzewski K; Roy RM; Niemela JE; Fleisher TA; Bonilla FA; Geha RS
    J Allergy Clin Immunol; 2004 Sep; 114(3):650-6. PubMed ID: 15356572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypohidrotic ectodermal dysplasia, osteopetrosis, lymphedema, and immunodeficiency in an infant with multiple opportunistic infections.
    Carlberg VM; Lofgren SM; Mann JA; Austin JP; Nolt D; Shereck EB; Davila-Saldana B; Zonana J; Krol AL
    Pediatr Dermatol; 2014; 31(6):716-21. PubMed ID: 23405946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OL-EDA-ID Syndrome: a Novel Hypomorphic NEMO Mutation Associated with a Severe Clinical Presentation and Transient HLH.
    Ricci S; Romano F; Nieddu F; Picard C; Azzari C
    J Clin Immunol; 2017 Jan; 37(1):7-11. PubMed ID: 27838798
    [No Abstract]   [Full Text] [Related]  

  • 6. EDA-ID and IP, two faces of the same coin: how the same IKBKG/NEMO mutation affecting the NF-κB pathway can cause immunodeficiency and/or inflammation.
    Fusco F; Pescatore A; Conte MI; Mirabelli P; Paciolla M; Esposito E; Lioi MB; Ursini MV
    Int Rev Immunol; 2015; 34(6):445-59. PubMed ID: 26269396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlating interleukin-12 stimulated interferon-γ production and the absence of ectodermal dysplasia and anhidrosis (EDA) in patients with mutations in NF-κB essential modulator (NEMO).
    Haverkamp MH; Marciano BE; Frucht DM; Jain A; van de Vosse E; Holland SM
    J Clin Immunol; 2014 May; 34(4):436-43. PubMed ID: 24682681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful allogeneic hemopoietic stem cell transplantation in a child who had anhidrotic ectodermal dysplasia with immunodeficiency.
    Dupuis-Girod S; Cancrini C; Le Deist F; Palma P; Bodemer C; Puel A; Livadiotti S; Picard C; Bossuyt X; Rossi P; Fischer A; Casanova JL
    Pediatrics; 2006 Jul; 118(1):e205-11. PubMed ID: 16769798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunodeficiency in Two Female Patients with Incontinentia Pigmenti with Heterozygous NEMO Mutation Diagnosed by LPS Unresponsiveness.
    Ohnishi H; Kishimoto Y; Taguchi T; Kawamoto N; Nakama M; Kawai T; Nakayama M; Ohara O; Orii K; Fukao T
    J Clin Immunol; 2017 Aug; 37(6):529-538. PubMed ID: 28702714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A hypermorphic IkappaBalpha mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency.
    Courtois G; Smahi A; Reichenbach J; Döffinger R; Cancrini C; Bonnet M; Puel A; Chable-Bessia C; Yamaoka S; Feinberg J; Dupuis-Girod S; Bodemer C; Livadiotti S; Novelli F; Rossi P; Fischer A; Israël A; Munnich A; Le Deist F; Casanova JL
    J Clin Invest; 2003 Oct; 112(7):1108-15. PubMed ID: 14523047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Challenges in the use of allogeneic hematopoietic SCT for ectodermal dysplasia with immune deficiency.
    Fish JD; Duerst RE; Gelfand EW; Orange JS; Bunin N
    Bone Marrow Transplant; 2009 Feb; 43(3):217-21. PubMed ID: 18794870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heritable defects of the human TLR signalling pathways.
    Puel A; Yang K; Ku CL; von Bernuth H; Bustamante J; Santos OF; Lawrence T; Chang HH; Al-Mousa H; Picard C; Casanova JL
    J Endotoxin Res; 2005; 11(4):220-4. PubMed ID: 16176658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation.
    Orange JS; Jain A; Ballas ZK; Schneider LC; Geha RS; Bonilla FA
    J Allergy Clin Immunol; 2004 Apr; 113(4):725-33. PubMed ID: 15100680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling.
    Döffinger R; Smahi A; Bessia C; Geissmann F; Feinberg J; Durandy A; Bodemer C; Kenwrick S; Dupuis-Girod S; Blanche S; Wood P; Rabia SH; Headon DJ; Overbeek PA; Le Deist F; Holland SM; Belani K; Kumararatne DS; Fischer A; Shapiro R; Conley ME; Reimund E; Kalhoff H; Abinun M; Munnich A; Israël A; Courtois G; Casanova JL
    Nat Genet; 2001 Mar; 27(3):277-85. PubMed ID: 11242109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent somatic mosaicism of NEMO in T cells of patients with X-linked anhidrotic ectodermal dysplasia with immunodeficiency.
    Kawai T; Nishikomori R; Izawa K; Murata Y; Tanaka N; Sakai H; Saito M; Yasumi T; Takaoka Y; Nakahata T; Mizukami T; Nunoi H; Kiyohara Y; Yoden A; Murata T; Sasaki S; Ito E; Akutagawa H; Kawai T; Imai C; Okada S; Kobayashi M; Heike T
    Blood; 2012 Jun; 119(23):5458-66. PubMed ID: 22517901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression in nuclear factor-κB essential modulator due to a novel splice-site mutation causes X-linked ectodermal dysplasia with immunodeficiency.
    Karakawa S; Okada S; Tsumura M; Mizoguchi Y; Ohno N; Yasunaga S; Ohtsubo M; Kawai T; Nishikomori R; Sakaguchi T; Takihara Y; Kobayashi M
    J Clin Immunol; 2011 Oct; 31(5):762-72. PubMed ID: 21720903
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific NEMO mutations impair CD40-mediated c-Rel activation and B cell terminal differentiation.
    Jain A; Ma CA; Lopez-Granados E; Means G; Brady W; Orange JS; Liu S; Holland S; Derry JM
    J Clin Invest; 2004 Dec; 114(11):1593-602. PubMed ID: 15578091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of immunodeficiency associated with NEMO mutation by umbilical cord blood transplantation using a reduced-intensity conditioning regimen.
    Tono C; Takahashi Y; Terui K; Sasaki S; Kamio T; Tandai S; Sato T; Kudo K; Toki T; Tachibana N; Yoshioka T; Nakahata T; Morio T; Nishikomori R; Ito E
    Bone Marrow Transplant; 2007 Jun; 39(12):801-4. PubMed ID: 17417663
    [No Abstract]   [Full Text] [Related]  

  • 19. Diagnosis and treatment in anhidrotic ectodermal dysplasia with immunodeficiency.
    Kawai T; Nishikomori R; Heike T
    Allergol Int; 2012 Jun; 61(2):207-17. PubMed ID: 22635013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific missense mutations in NEMO result in hyper-IgM syndrome with hypohydrotic ectodermal dysplasia.
    Jain A; Ma CA; Liu S; Brown M; Cohen J; Strober W
    Nat Immunol; 2001 Mar; 2(3):223-8. PubMed ID: 11224521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.